A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP Redazione 18 Febbraio 2021 ...
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia Redazione 18 Febbraio 2021 ...
Early mortality benefit with COVID‐19 convalescent plasma: a matched control study Redazione 18 Febbraio 2021 ...
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults Redazione 18 Febbraio 2021 ...